Injectable Drug Delivery Resources

  1. Vials Vs. Cryobags For Cryopreservation Of Therapeutically Relevant T Cells 7/20/2023

    Explore how COP 50 mL vials could serve as a basis for cell therapies and storage solution to help facilitate the manufacture and commercialization of cell products.

  2. A New Mindset For Combination Product Development 6/15/2022

    As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.

  3. Factors To Consider When Selecting A CDMO For Complex Injectables Development And Manufacture 3/1/2022

    The right CDMO partner will have specialized technologies for complex injectable development along with the equipment, facilities and operations to adopt GMP practices with a "laboratory setting."

  4. CDMOs Step Up Parenteral Manufacturing Support 7/4/2022

    Jeff Clement, Executive Director, CDMO Business Development North America, discusses the impact of the pandemic on CDMOs and parenteral market trends.

  5. Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage 3/24/2023

    Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.

  6. Utilizing Robotic Aseptic Filling Systems To Meet Industry Needs 5/19/2022

    An aseptic filling and closing machine solution allowed Catalent to reliably process a wide range of both trayed and nested vials for their client product needs.

  7. Deploying A Circular Economy For Medical Devices 9/10/2024

    A circular economy prioritizes sustainability throughout the supply chain by eliminating waste, circulating products and materials, and regenerating nature.

  8. Autoinjectors: A Revolutionary Leap In Drug Delivery 2/7/2024

    Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.

  9. Characterization & Delivery Of Ultra-Viscous & Non-Newtonian Formulations 3/2/2022

    Discover how to identify characteristics at the earliest stage, a vital step in autoinjector device platform development, with the use of the innovative Injection Characterization System (ICS).

  10. Is It Ever Too Soon To Start Your Performance Testing Assessment?

    Developing a safe and effective injectable combination product involves performing risk assessments, establishing a set of Critical Quality Attributes (CQAs), and performing design verification testing.